An Open-Label, Randomized, Controlled Multi-Center Study of the Efficacy of Daromun (L19IL2+L19TNF) Neoadjuvant Intratumoral Treatment Followed by Surgery and Adjuvant Therapy Versus Surgery and Adjuvant Therapy in Clinical Stage IIIB/C Melanoma Pati

Clinical Trial Grant

Duke Scholars

Principal Investigator Georgia Marie Beasley Surgical Oncology

Administered By

Duke Cancer Institute

Awarded By

Philogen S.p.A

Start Date

September 30, 2022

End Date

September 28, 2027

Administered By

Duke Cancer Institute

Awarded By

Philogen S.p.A

Start Date

September 30, 2022

End Date

September 28, 2027